Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leflunomide plus prednisone versus cyclophosphamide plus prednisone for PLA2R-associated primary membranous nephropathy
ChiCTR1900027627Phase 4Completed
- Sponsor
- Bengbu Medical University
- Start
- Dec 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of leflunomide, prednisone and cyclophosphamide in idiopathic membranous glomerulonephritis (IMG) (2 arms), sponsored by Bengbu Medical University. Primary endpoints: Serum albumin, 24-hour urinary protein and 1 more. Started Dec 2017; status: completed.
02
Drugs
leflunomideprednisonecyclophosphamide
03
Conditions
idiopathic membranous glomerulonephritis (IMG)
Beyond the preview
Go deeper on ChiCTR1900027627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027627.